Pancreatic cancer
Results
Phase 2
This trial looked at 2 different ways of having nab-paclitaxel and gemcitabine chemotherapy for pancreatic cancer that has spread to another part of the body.
Recruitment start: 1 January 2014
Recruitment end: 23 March 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Pippa Corrie
Cambridge University Hospitals NHS Foundation Trust
Celgene
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Cancer Research UK Cambridge Institute
Last reviewed: 10 June 2018
CRUK internal database number: 11741